Literature DB >> 8609385

Fc receptor-induced expression of Fas ligand on activated NK cells facilitates cell-mediated cytotoxicity and subsequent autocrine NK cell apoptosis.

C M Eischen1, J D Schilling, D H Lynch, P H Krammer, P J Leibson.   

Abstract

Ligation of the Fc gamma R on NK cells by Ab-coated target cells initiates a mode of killing referred to as antibody-dependent cell-mediated cytotoxicity (ADCC). There is clear evidence that the release from NK cells of granules containing pore-forming proteins and serine proteases can result in the rapid (within minutes) cell death of Ab-coated targets. However, little information is available as to whether NK cells can initiate subsequent killing through granule-independent mechanisms and as to the mechanisms that down-regulate NK cell-mediated responses. We demonstrate in this study that FcR stimulation of activated human NK cells not only induces granule exocytosis, but also subsequently results in the transcriptional up-regulation of Fas ligand. These FcR-stimulated NK cells can then kill targets that bear Fas (CD95/APO-1), as this cytotoxicity can be inhibited by blocking Abs to the Fas receptor. In addition, as resting NK cells become activated, their Fas receptors become competent to deliver autocrine suicide signals. We demonstrate in this work that the interaction of Fas ligand on the FcR-stimulated NK cells with their Fas receptors can result in apoptosis of the NK cells. These results suggest that the FcR-induced expression of Fas ligand on activated NK cells can critically influence the capacity of these cells to mediate paracrine and autocrine cell death.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8609385

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.

Authors:  J Wu; J C Edberg; P B Redecha; V Bansal; P M Guyre; K Coleman; J E Salmon; R P Kimberly
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  EBI3 regulates the NK cell response to mouse cytomegalovirus infection.

Authors:  Helle Jensen; Shih-Yu Chen; Lasse Folkersen; Garry P Nolan; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-31       Impact factor: 11.205

3.  Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.

Authors:  M W Bennett; J O'connell; G C O'sullivan; D Roche; C Brady; J Kelly; J K Collins; F Shanahan
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

4.  Expression of Fas (CD95/APO-1) ligand by human breast cancers: significance for tumor immune privilege.

Authors:  J O'Connell; M W Bennett; G C O'Sullivan; J O'Callaghan; J K Collins; F Shanahan
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

5.  NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors.

Authors:  Alexander W MacFarlane; Mowafaq Jillab; Mitchell R Smith; R Katherine Alpaugh; Marion E Cole; Samuel Litwin; Michael M Millenson; Tahseen Al-Saleem; Adam D Cohen; Kerry S Campbell
Journal:  Oncoimmunology       Date:  2017-05-19       Impact factor: 8.110

6.  Live cell evaluation of granzyme delivery and death receptor signaling in tumor cells targeted by human natural killer cells.

Authors:  Alexandra C Vrazo; Adrianne E Hontz; Sarah K Figueira; Braeden L Butler; Julie M Ferrell; Brock F Binkowski; Jinzhu Li; Kimberly A Risma
Journal:  Blood       Date:  2015-06-29       Impact factor: 22.113

7.  Fas ligand deficiency in HIV disease.

Authors:  S Sieg; D Smith; Z Yildirim; D Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-27       Impact factor: 11.205

8.  The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanisms.

Authors:  Tatiana Pazina; Ashley M James; Alexander W MacFarlane; Natalie A Bezman; Karla A Henning; Christine Bee; Robert F Graziano; Michael D Robbins; Adam D Cohen; Kerry S Campbell
Journal:  Oncoimmunology       Date:  2017-06-16       Impact factor: 8.110

9.  Targeting of natural killer cells by rabbit antithymocyte globulin and campath-1H: similar effects independent of specificity.

Authors:  Diana Stauch; Annelie Dernier; Elizabeth Sarmiento Marchese; Kristina Kunert; Hans-Dieter Volk; Johann Pratschke; Katja Kotsch
Journal:  PLoS One       Date:  2009-03-05       Impact factor: 3.240

10.  Fas receptor is required for estrogen deficiency-induced bone loss in mice.

Authors:  Natasa Kovacic; Danka Grcevic; Vedran Katavic; Ivan Kresimir Lukic; Vladimir Grubisic; Karlo Mihovilovic; Hrvoje Cvija; Peter Ian Croucher; Ana Marusic
Journal:  Lab Invest       Date:  2010-01-18       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.